NewLimit
NewLimit is a biotechnology company working to extend human healthspan by developing epigenetic reprogramming therapies.
55 employees · est. 2022 · South San Francisco, United...
Viome Life Sciences
We're on a mission to decode human biology in order to prevent and reverse chronic diseases, cancers, and aging.
30 employees · est. 2016 · Bellevue, United States
Viome Life Sciences is the older company (2022 vs 2016); NewLimit is the larger of the two.
Side-by-Side Comparison
| Metric | NewLimit | Viome Life Sciences |
|---|---|---|
| Founded | ||
| Founded | 2022 | 2016 older |
| Headquarters | ||
| Headquarters | South San Francisco, United States | Bellevue, United States |
| Employees | ||
| Employees | 55 larger | 30 |
| Industry | ||
| Industry | Biotechnology, Health Care | Health Care |
| Funding Stage | ||
| Funding Stage | Series C | Series Unknown |
| Total Funding | ||
| Total Funding | $650.00M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 4 | 1 |
| Services | ||
| Services | Development of anti-aging medicines, Epigenetic reprogramming research, Genomic testing and analysis, AI-driven therapeutic design | Not tracked yet |
| Target Customers | ||
| Target Customers | Biotechnology companies, Healthcare providers, Research institutions, Aging population | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Healthspan Extension, Epigenetic Reprogramming, Age-related Diseases, Regenerative Medicine, Functional Genomics, Therapeutic Development, Pooled Perturbation Screening, Machine Learning In Biotech, Epigenetics, Disease Biology, Genomic Research, Unmet Medical Needs, Cellular Regeneration | Genomics, Microbiome Analysis, Precision Medicine, AI In Healthcare, Chronic Disease Prevention, Cancer Diagnostics, Aging Research, Molecular Biology, Precision Therapeutics, Predictive Medicine |
| Website | ||
| Website | newlimit.com | viomelifesciences.com |
About NewLimit
NewLimit is a promising player in the Biotechnology and Health Care industries, aiming to revolutionize human healthspan through cutting-edge epigenetic reprogramming therapies. Founded in 2022 and headquartered in the United States, the company focuses on treating age-related diseases by rejuvenati...
About Viome Life Sciences
Viome Life Sciences, founded in 2016, is dedicated to decoding human biology to prevent and reverse chronic diseases, cancers, and aging. The company's Consumer Services (VIOME) offers a direct-to-consumer healthcare test analyzing microbial and human gene expressions utilizing proprietary technolog...
We will tell you when either one moves
BounceWatch watches NewLimit and Viome Life Sciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at NewLimit and Viome Life Sciences — by email.
Frequently Asked Questions
Compare NewLimit with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at NewLimit on 15 Jun 2026, and Viome Life Sciences on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.